Latest News & Updates

Biologics Contribute to Growth in Pharma Products Cold-Chain Market

In its September issue, Pharmaceutical Commerce details the previous and expected contributions of biologic products to its forecast of cold-chain market growth predicting sales of cold-chain drugs and biologics will outpace overall industry growth through 2022. It is reported that “as of 2018, global...

Wednesday, September 12, 2018 | Read More

FDA Researchers Explore Fundamental Chemical Reaction that Could Threaten the Quality of Therapeutic Protein Products

In a recent news release the FDA described research it has conducted regarding detection of protein carbonylation, an oxidative reaction that may occur in therapeutic protein drug products during manufacture, storage, use, and transport potentially causing structural alterations and threatening stability,...

Tuesday, September 11, 2018 | Read More

Sentry representatives attend DCAT week

Sentry BioPharma Services is pleased to announce delegates from Sentry’s Business Development team will be in New York City attending the Drug, Chemical & Associated Technologies Association (DCAT) Week March 19th -22nd. The four-day conference brings together key sourcing, procurement and business...

Monday, March 19, 2018 | Read More

Pharmaceutical Life Cycle Management

Pharmaceutical Supply Chain Solutions: Timely and Cost-Effective Solutions for Every Phase of Drug Development

The pharmaceutical product life cycle presents unique challenges. Stability studies conducted in early clinical phases may require different solutions than those needed to meet scalability concerns for a product launch.  Sentry BioPharma Services furnishes start-to-finish pharmaceutical supply chain solutions, including development support, returns, drug reverse logistics and the development of custom services on an as-needed basis. Sentry's focused guardianship empowers clients to: 

  • Enhance inventory control and transparency
  • Improve collaboration with channel partners - Learn how our strategic partnership with Vetter can optimize and strengthen your drug development supply chain.
  • Maximize launch margins
  • Reduce risks of temperature deviation

As a valued supply chain partner, Sentry oversees storage, distribution, data administration, project management, security and pharmaceutical reverse logistics. Sentry holds licensing and accreditation for drug wholesale and distribution while providing:

  • Professional account management
  • Operations and quality responsiveness
  • Reduced product transfer risks
  • On-demand solutions

For more information about how Sentry's pharmaceutical life cycle management expertise and capabilities unite to advance your product into commercialization, contact Sentry via email or by phone at 1-866-757-7400.